. Author manuscript; available in PMC: 2019 Mar 1.

Published in final edited form as: Inflamm Intest Dis. 2017 Nov 18;2(3):147–153. doi: 10.1159/000484347

Table 5. Asians' risk of developing worse outcomes, adjusting for baseline disease behavior and remission status.

Indicator of more aggressive IBD	Crohn's Disease Asian Risk Ratio (ref: white)	95% CI	Ulcerative Colitis Asian Risk Ratio (ref: white)	95% CI
IBD-related surgery	0.69	0.24-2.04	0.91	0.30-2.70
IBD-related hospitalization	0.58	0.28-1.21	0.83	0.45-1.54
New biologic prescription	1.99	0.96-4.11	1.27	0.50-3.20
New steroid prescription	1.41	0.20-9.89	1.11	0.16-7.90
Relapse^*	0.64	0.22-1.86	0.86	0.39-1.86

Defined as a modified Harvey Bradshaw Index ≥ 5 for Crohn's disease and Simple Clinical Colitis Activity Index >2 for ulcerative colitis, for those in remission at baseline